These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32931060)

  • 1. Patient literacy and awareness of medicine safety.
    See M; Butcher BE; Banh A
    Int J Pharm Pract; 2020 Dec; 28(6):552-560. PubMed ID: 32931060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of patient understanding of their conventional cardiac medicines and herbal prepared/derived products: preliminary survey and interviews with selected community-dwelling elderly patients in the Philippines.
    Jazul JP; Arciga TMG; Ante MAC; Berlin DGB; Ravana LFL; Reyes SA; Singh J
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):403-413. PubMed ID: 34214303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' perceptions and communication of risk for alertness impairing medications.
    Jomaa I; Odisho M; Cheung JMY; Wong K; Ellis JG; Smyth T; Saini B
    Res Social Adm Pharm; 2018 Jan; 14(1):31-45. PubMed ID: 28118967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.
    Tarn DM; Paterniti DA; Williams BR; Cipri CS; Wenger NS
    J Am Geriatr Soc; 2009 Mar; 57(3):462-9. PubMed ID: 19175439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia.
    Panickar R; Aziz Z; Kamarulzaman A
    BMC Public Health; 2022 Jul; 22(1):1293. PubMed ID: 35788213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand.
    Patsuree A; Krska J; Jarernsiripornkul N
    Expert Opin Drug Saf; 2016; 15(3):287-95. PubMed ID: 26750422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communication needs of patients with altered hearing ability: Informing pharmacists' patient care services through focus groups.
    Ferguson M; Liu M
    J Am Pharm Assoc (2003); 2015; 55(2):153-60. PubMed ID: 25700133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Interprofessional Evaluation of Health Literacy Communication Practices of Physicians, Pharmacists, and Nurses at Public Hospitals in Penang, Malaysia.
    Rajah R; Hassali MA; Lim CJ
    Ann Pharmacother; 2018 Apr; 52(4):345-351. PubMed ID: 29078711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informing patients about medicines--a hospital in-patient survey in England.
    Krska J; Morecroft CW
    Patient Educ Couns; 2013 Feb; 90(2):276-8. PubMed ID: 23083903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring patient expectations for pharmacist-provided literacy-sensitive communication.
    Collum JL; Marcy TR; Stevens EL; Burns CF; Miller MJ
    Res Social Adm Pharm; 2013; 9(5):626-32. PubMed ID: 22835713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The certainty in consumers' willingness to accept pharmacist-provided medication therapy management services.
    Brown LM; Rashrash ME; Schommer JC
    J Am Pharm Assoc (2003); 2017; 57(2):211-216. PubMed ID: 28285775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pharmacists in patients' education on medication.
    Alkhawajah AM; Eferakeya AE
    Public Health; 1992 May; 106(3):231-7. PubMed ID: 1603927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist and general practitioner ambivalence about providing written medicine information to patients-a qualitative study.
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2013; 9(5):517-30. PubMed ID: 23567071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacists require additional support to develop capacity in delivering alcohol-related health information to older adults.
    Dare J; Wilkinson C; Garlepp M; Lo J; Allsop S
    Int J Pharm Pract; 2017 Aug; 25(4):301-310. PubMed ID: 27766721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Pharmacist Consultations for Nonprescription Laxatives in Japan: An Online Survey.
    Shibata K; Matsumoto A; Nakagawa A; Akagawa K; Nakamura A; Yamamoto T; Kurata N
    Biol Pharm Bull; 2016; 39(11):1767-1773. PubMed ID: 27803447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.